Copyright 2024 The Associated Press. All Rights Reserved. Antonio Guterres, United Nations secretary-general, speaks during a ...

EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...

Harding Loevner International Equity ADR composite rose 9.2%, gross, in Q3 2024, outpacing the 8.2% gain of the MSCI All ...

Novo Holdings is the controlling shareholder of Danish drugmaker Novo Nordisk, whose profits from blockbuster weight-loss ...

COVID-19 vaccination coverage has progressed unevenly throughout the world. Moreover, 1.01 and 1.43 doses for each person are ...

Australia’s audit office will probe the Morrison government’s $2 billion deal with US pharmaceutical giant Moderna to set up ...

Novavax Inc.’s stock fell 4% Tuesday after the company cut its full-year guidance, offsetting a narrower-than-expected ...

with which it signed a licensing deal earlier this year to sell its COVID vaccine from 2025 in several markets, including the ...

Under the new agreement, GSK has assumed full control of the development, manufacturing and global commercialization of mRNA vaccine candidates against influenza and COVID-19, including combinations.

Novavax (NASDAQ:NVAX) shares lost ~12% in the premarket on Tuesday after the Gaithersburg, MD-based biotech, with its Q3 2024 ...

Advanced preparation for Sanofi to assume lead commercial responsibility of Nuvaxovid™ COVID-19 vaccine for 2025-2026 ...

Early in 2021, South Africa stopped offering the AstraZeneca-Oxford vaccine when clinical trials found it provided inadequate protection against moderate to severe COVID-19 caused by ... and rapidly ...